Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4787863
Max Phase: Preclinical
Molecular Formula: C72H99N3Na14O97S14
Molecular Weight: 3021.56
Molecule Type: Unknown
Associated Items:
ID: ALA4787863
Max Phase: Preclinical
Molecular Formula: C72H99N3Na14O97S14
Molecular Weight: 3021.56
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H](O[C@@H]([C@H](O[C@@H]2O[C@@H](C)[C@@H](OS(=O)(=O)[O-])[C@@H](O)[C@@H]2OS(=O)(=O)O)[C@@H](O)CO)[C@H](O)C(=O)[O-])O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@@H]1O[C@@H]1O[C@H](C(=O)[O-])[C@@H](O[C@@H]2O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H](O[C@@H]3O[C@H](C(=O)[O-])[C@@H](O[C@@H]4O[C@H](COS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H](O[C@@H]5OC(C(=O)[O-])=C[C@H](O[C@@H]6O[C@@H](C)[C@@H](OS(=O)(=O)[O-])[C@@H](OS(=O)(=O)O)[C@@H]6O)[C@H]5O)[C@H]4NC(C)=O)[C@H](O[C@@H]4O[C@@H](C)[C@@H](OS(=O)(=O)[O-])[C@@H](O)[C@@H]4OS(=O)(=O)O)[C@H]3O)[C@H]2NC(C)=O)[C@H](O[C@@H]2O[C@@H](C)[C@@H](OS(=O)(=O)[O-])[C@@H](O)[C@@H]2OS(=O)(=O)O)[C@H]1O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C72H113N3O97S14.14Na/c1-13-37(162-176(106,107)108)30(82)52(170-184(130,131)132)70(143-13)151-41(20(80)9-76)48(33(85)60(91)92)155-63-26(73-17(5)77)46(43(167-181(121,122)123)23(148-63)10-139-173(97,98)99)153-68-34(86)49(156-71-53(171-185(133,134)135)31(83)38(14(2)144-71)163-177(109,110)111)56(58(160-68)62(95)96)159-65-28(75-19(7)79)47(44(168-182(124,125)126)25(150-65)12-141-175(103,104)105)154-69-35(87)50(157-72-54(172-186(136,137)138)32(84)39(15(3)145-72)164-178(112,113)114)55(57(161-69)61(93)94)158-64-27(74-18(6)78)45(42(166-180(118,119)120)24(149-64)11-140-174(100,101)102)152-66-29(81)21(8-22(147-66)59(89)90)146-67-36(88)51(169-183(127,128)129)40(16(4)142-67)165-179(115,116)117;;;;;;;;;;;;;;/h8,13-16,20-21,23-58,63-72,76,80-88H,9-12H2,1-7H3,(H,73,77)(H,74,78)(H,75,79)(H,89,90)(H,91,92)(H,93,94)(H,95,96)(H,97,98,99)(H,100,101,102)(H,103,104,105)(H,106,107,108)(H,109,110,111)(H,112,113,114)(H,115,116,117)(H,118,119,120)(H,121,122,123)(H,124,125,126)(H,127,128,129)(H,130,131,132)(H,133,134,135)(H,136,137,138);;;;;;;;;;;;;;/q;14*+1/p-14/t13-,14-,15-,16-,20-,21-,23+,24+,25+,26+,27+,28+,29+,30+,31+,32+,33-,34+,35+,36-,37+,38+,39+,40+,41+,42-,43-,44-,45+,46+,47+,48+,49+,50+,51-,52-,53-,54-,55-,56-,57-,58-,63-,64-,65-,66-,67-,68+,69+,70-,71-,72-;;;;;;;;;;;;;;/m0............../s1
Standard InChI Key: AZBLBZZCWXHDFB-NQYQXAKGSA-A
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3021.56 | Molecular Weight (Monoisotopic): 3019.0092 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Sun H,Gao N,Ren L,Liu S,Lin L,Zheng W,Zhou L,Yin R,Zhao J. (2020) The components and activities analysis of a novel anticoagulant candidate dHG-5., 207 [PMID:32942073] [10.1016/j.ejmech.2020.112796] |
Source(1):